Description

This panel brings together top executives from leading neuromodulation and minimally invasive spine companies to discuss the current and future state of interventional pain therapies. Each leader shares insights on growth, innovation, compliance, and the need for collaboration across the industry to combat negative public perceptions, regulatory hurdles, and payer resistance. Key themes include expanding patient access, building objective data to validate therapies, elevating compliance standards, and strategically investing in advocacy and education. Panelists emphasize that while competition fuels progress, unity is essential to protect and grow the field for the benefit of patients worldwide.